Date: {{$ActivityAssignDate}}

Dear Dr. {{ $doctorName }},

Subject : To participate in a cross-sectional survey to assess disease perspective and management practices of Allergic Rhinitis in India

Allergic rhinitis is one of the most common allergic diseases worldwide, affecting about 10-25% of the population. It is one of the top ten reasons for visits to primary care physicians. The burden of allergic rhinitis is enormous, constituting about 55% of all allergies. About 20-30% of the Indian population suffers from at least one allergic disease. The reported incidence of allergic rhinitis in India also ranges between 20% and 30%. Studies have shown that the prevalence of allergic rhinitis has been increasing in India over the past few years.

Allergic rhinitis is frequently caused by exposure to perennial or seasonal allergens present in the indoor and outdoor environment, the most common ones being: Pollens (grass, trees, weeds), house dust mites, pets, and molds. Avoidance of triggers, especially in those with seasonal symptoms, is encouraged, although it is not always practical. Precautions can be taken to avoid dust mites, animal dander, and upholstery, though this can require significant lifestyle changes that may not be acceptable to the patient.

Pharmacological options include antihistamines, intranasal steroids, leukotriene receptor antagonists, and immunotherapy. Intranasal corticosteroid therapy can be as monotherapy or in combination with oral antihistamines in patients in patients with mild, moderate, or severe symptoms.

This survey will help:

• To understand the epidemiology of AR
• To Identify the abnormal immune response in the etiology of AR
• To understand the disease profile, its diagnosis, and the use of various drugs and combinations in the treatment of AR in India
• To describe the use of steroids, antihistamines, leukotriene receptor antagonists, and immunotherapy in the treatment of AR in India
• To understand the place of therapy of such drugs and their combinations in the management of AR in India

If you agree to participate, you must provide an assessment response, to the standard questionnaire form. A link will be provided for the same on your registered email address.

We trust you and we are partners in safe and effective drug therapy. In that spirit, we hope you will consent to participate in this survey.